HomeQuestion

Does paraneoplastic pemphigus improve after treatment of the underlying malignancy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Are there patients with pemphigus whom you plan to give additional doses of rituximab even if they are in complete remission at six months from their initial dose?

How have you applied the findings of this trial to your current approach to prescribing rituximab for pemphigus patients?

What is your approach to tapering off rituximab in a patient with pemphigus who seems to be remission?

Are there subgroups of patients with pemphigus in whom you prioritize lower-dose rituximab regimens?

How do you counsel patients with pemhigus on the main safety benefits of a low or ultra low dose rituximab regimen?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.